ANAND RAJAN,APGAR JAMES M.,BIFTU TESFAYE,CHEN PING,CHU LIN,COLANDREA VINCENT J.,DONG GUIZHEN,DROPINSKI JAMES F.,FENG DANQING,HICKS JACQUELINE D.,JIANG JINLONG,KIM ALEXANDER J.,LEAVITT KENNETH J.,LI BI
申请号：
NZ61362612
公开号：
NZ613626A
申请日:
2012.02.23
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed herein are imidazo[4,5-b]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, wherein T is N； U is CR1； V is CR2； W is CR4； X is -O- or &ndash；O-CH2, and the other variables shown in formula (I) are as defined in the specification. These imidazo[4,5-b]pyridine derivatives are suitable for the treatment of a disorder, condition, or disease selected from the group consisting of: Type 2 diabetes, hyperglycemia, Metabolic Syndrome, obesity, hypercholesterolemia, and hypertension, in a mammal in need thereof.
